Geroldinger A

ORCID: 0000-0002-4659-4911 · 1 paper in corpus

diagnostic-accuracy 2021

Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient's plasma - a prospective trial

BMC cancer ·doi:10.1186/s12885-021-08682-y

BACKGROUND: Trial on five plasma biomarkers (CA125, HE4, OPN, leptin, prolactin) and their possible role in differentiating benign from malignant ovarian tumors. METHODS: In this unicentric prospective trial preoperative blood samples of 4…